Locations
Redwood City, CA, USA · Redwood Shores, Redwood City, CA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2010
Coherus Biosciences is a biopharmaceutical company focused on developing and commercializing next-generation immuno-oncology therapies aimed at extending patient survival across various tumor types. The company has successfully launched LOQTORZI™ (toripalimab-tpzi), the first FDA-approved therapy for recurrent or metastatic nasopharyngeal carcinoma, and is advancing multiple clinical-stage candidates targeting the tumor microenvironment. With a strong commitment to immuno-oncology and a proven track record in biosimilars, Coherus is well-positioned to improve treatment access and outcomes for patients with life-altering diseases.
Something looks off?On-site & Remote